Protein arrays are lagging behind in their implementation relative to DNA arrays because proteins are harder to produce and keep active. But in the September Nature Biotechnology de Wildt et al.

Reverse phase protein array is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body fluids.

Rigorous specificity analysis is critical for successful drug development and a safety requirement for antibody-based therapies, such as CAR-T, entering IND. Tissue cross-reactivity (TCR) studies have ...

The AntibodyArray is a membrane on which antibodies to a variety of protein ligands are immobilized. Users of the technology apply a cell lysate to the array and incubate to allow proteins to bind to ...

Co announces that it has extended its collaboration agreement with the Medical University of South Carolina. In partnership with Lumera scientists, M.U.S.C researchers intend to develop an antibody ...

Monoclonal antibodies (mAbs) are one of the most successful therapeutic drug classes, generating lucrative sales for the pharmaceutical industry. In 2016, more than 20 therapeutic antibodies gained ...